Literature DB >> 2725825

The long-term administration of L-cycloserine to mice: specific reduction of cerebroside level.

K S Sundaram1, M Lev.   

Abstract

Short-term experiments in which L-cycloserine, the inhibitor of 3-ketodihydrosphinogosine synthase, was injected subcutaneously in young mice have shown that cerebroside synthesis is inhibited specifically. Studies on the effect of long term L-cycloserine treatment on sphingolipid synthesis were performed to determine whether mice could tolerate continued cerebroside reduction and whether or not the synthesis of other sphingolipids would be inhibited. L-cycloserine, when injected at a low dose for a period of two months resulted in significantly reduced brain cerebroside level with little or no reduction in sulfatide, ganglioside, or sphingomyelin levels; liver and spleen glucocerebroside levels were also significantly reduced. The rate of cerebroside synthesis in brain was greatly reduced, whereas synthesis of sulfatides was much less affected by L-cycloserine indicating that a portion of newly synthesized galactocerebroside is shunted to synthesis of sulfatides.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2725825     DOI: 10.1007/bf00971318

Source DB:  PubMed          Journal:  Neurochem Res        ISSN: 0364-3190            Impact factor:   3.996


  16 in total

1.  ISOTOPIC STUDIES OF THE BIOSYNTHESIS OF THE CEREBROSIDE FATTY ACIDS IN RATS.

Authors:  A K HAJRA; N S RADIN
Journal:  J Lipid Res       Date:  1963-07       Impact factor: 5.922

2.  Phosphorus assay in column chromatography.

Authors:  G R BARTLETT
Journal:  J Biol Chem       Date:  1959-03       Impact factor: 5.157

3.  Quantitative estimation of sialic acids. II. A colorimetric resorcinol-hydrochloric acid method.

Authors:  L SVENNERHOLM
Journal:  Biochim Biophys Acta       Date:  1957-06

4.  Observations on the biosynthesis of rat brain ceramide and cerebroside in vivo.

Authors:  T P Carter; J Kanfer
Journal:  J Neurochem       Date:  1974-09       Impact factor: 5.372

5.  Specificity in ceramide biosynthesis from long chain bases and various fatty acyl coenzyme A's by brain microsomes.

Authors:  P Morell; N S Radin
Journal:  J Biol Chem       Date:  1970-01-25       Impact factor: 5.157

Review 6.  Biosynthesis of the sphingoid bases: a provocation.

Authors:  N S Radin
Journal:  J Lipid Res       Date:  1984-12-15       Impact factor: 5.922

7.  Warfarin administration reduces synthesis of sulfatides and other sphingolipids in mouse brain.

Authors:  K S Sundaram; M Lev
Journal:  J Lipid Res       Date:  1988-11       Impact factor: 5.922

8.  L-cycloserine inhibition of sphingolipid synthesis in the anaerobic bacterium Bacteroides levii.

Authors:  K S Sundaram; M Lev
Journal:  Biochem Biophys Res Commun       Date:  1984-03-15       Impact factor: 3.575

9.  Inhibition of sphingolipid synthesis by cycloserine in vitro and in vivo.

Authors:  K S Sundaram; M Lev
Journal:  J Neurochem       Date:  1984-02       Impact factor: 5.372

10.  Inhibition of cerebroside synthesis in the brains of mice treated with L-cycloserine.

Authors:  K S Sundaram; M Lev
Journal:  J Lipid Res       Date:  1985-04       Impact factor: 5.922

View more
  3 in total

1.  Inhibition of serine palmitoyltransferase reduces Aβ and tau hyperphosphorylation in a murine model: a safe therapeutic strategy for Alzheimer's disease.

Authors:  Hirosha Geekiyanage; Aditi Upadhye; Christina Chan
Journal:  Neurobiol Aging       Date:  2013-03-23       Impact factor: 4.673

2.  Methamphetamine accelerates cellular senescence through stimulation of de novo ceramide biosynthesis.

Authors:  Giuseppe Astarita; Agnesa Avanesian; Benedetto Grimaldi; Natalia Realini; Zuzana Justinova; Leight V Panlilio; Abdul Basit; Steven R Goldberg; Daniele Piomelli
Journal:  PLoS One       Date:  2015-02-11       Impact factor: 3.240

3.  Substrate Reduction Therapy for Krabbe Disease: Exploring the Repurposing of the Antibiotic D-Cycloserine.

Authors:  Steven M LeVine; Sheila Tsau
Journal:  Front Pediatr       Date:  2022-01-18       Impact factor: 3.418

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.